| Accession Number: | 0001209191-14-055054 |
| Date: | 2014-08-27 |
| Issuer: | AUSPEX PHARMACEUTICALS, INC. (ASPX) |
| Original Submission Date: |
CMEA VENTURES VII LP
ONE LETTERMAN DRIVE
BUILDING C, SUITE CM500
SAN FRANCISCO, CA 94129
CMEA VENTURES VII (PARALLEL) LP
ONE LETTERMAN DRIVE
BUILDING C, SUITE CM500
SAN FRANCISCO, CA 94129
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2014-08-27 | S | 16,965 | d | $21.88 | 3,742,907 | direct | ||
| COMMON STOCK | 2014-08-27 | S | 435 | d | $21.88 | 96,022 | indirect | ||
| COMMON STOCK | 2014-08-28 | S | 11,895 | d | $22.24 | 3,731,012 | direct | ||
| COMMON STOCK | 2014-08-28 | S | 305 | d | $22.24 | 95,717 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the shares sold on this date were sold in multiple transactions. the price is the weighted average price per share; the actual sales price per share ranged from $21.425 to $22.54. |
| f2 | the shares sold on this date were sold in multiple transactions. the price is the weighted average price per share; the actual sales price per share ranged from $21.70 to $22.785. |
